As of 2025-07-09, the EV/EBITDA ratio of Arena Pharmaceuticals Inc (ARNA) is -10.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARNA's latest enterprise value is 5,982.02 mil USD. ARNA's TTM EBITDA according to its financial statements is -545.06 mil USD. Dividing these 2 quantities gives us the above ARNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 13.5x | 12.8x |
| Forward P/E multiples | 13.6x - 28.6x | 20.6x |
| Fair Price | (117.60) - (116.54) | (144.65) |
| Upside | -217.6% - -216.6% | -244.7% |
| Date | EV/EBITDA |